CYAD CYAD

Celyad Oncology Share Price

2.13
0.0299 (1.42%)
Upgrade to Real-Time
Afterhours (Closed)
2.13
Volume 3,752
Bid Price 1.29
Ask Price 2.24
News -
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Celyad Oncology SA CYAD NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.0299 1.42% 2.13 18:00:07
Open Price Low Price High Price Close Price Prev Close
1.9058 1.9058 2.155 2.13 2.1001
Trades Volume VWAP Dollar Volume Avg Volume
21 3,752  2.07  7,767 -
Last Trade Time Type Quantity Stock Price Currency
16:00:01 100  2.13 USD

Period:

Draw Mode:

Celyad Oncology SA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 48.13M 22.59M 22.59M  -  - -1.93 -1.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Celyad Oncology

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

CYAD Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in the pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.


Your Recent History
NASDAQ
CYAD
Celyad Onc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.